NCT00203762 Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care Status UNKNOWN Phase NA
NCT00201123 Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs Status COMPLETED Phase PHASE2
NCT00192556 Food Incentives for TB Treatment Compliance in East Timor (FITTCET) Status COMPLETED Phase NA
NCT00173264 Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis Status UNKNOWN Phase N/A
NCT00172783 PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period Status UNKNOWN Phase N/A
NCT00164463 TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment Status COMPLETED Phase PHASE2
NCT00164450 TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection Status COMPLETED Phase NA
NCT00164281 Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana Status COMPLETED Phase PHASE4
NCT00157066 Effects of Vitamin D Supplementation on Antimycobacterial Immunity Status COMPLETED Phase NA
NCT00146302 Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries? Status COMPLETED Phase PHASE4
NCT00145184 Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis Status TERMINATED Phase PHASE3
NCT00144417 TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment Status COMPLETED Phase PHASE2
NCT00134342 Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations Status COMPLETED Phase N/A
NCT00130325 A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts Status COMPLETED Phase NA